INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
Recruiting · NCT07224321 · Registry updated 2026-08-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes | Insulin Resistance, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Respiratory Aspiration, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperinsulinism, immune system disorder, metabolic disease, respiratory system disorder, type 1 diabetes mellitus | Recruiting | Phase 2 | 2026-08-13 | NCT07224321 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jaeb Center for Health Research | 37 |
| Mannkind Corporation | 4 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Barbara Davis Center for Diabetes Young Adult Clinic | Aurora | United States | 1 |
| Baylor College of Medicine | Houston | United States | 306 |
| Children's Hospital Los Angeles | Los Angeles | United States | 226 |
| Indiana University | Indianapolis | United States | 160 |
| Joslin Diabetes Center | Boston | United States | 37 |
| University of California San Francisco | San Francisco | United States | 80 |
| University of Florida | Gainsville | United States | 3 |
| University of Oklahoma Health Sciences Center | Oklahoma City | United States | 491 |
| University of Virginia | Charlottesville | United States | 136 |
| Yale University | New Haven | United States | 44 |